Clinical Trial Detail

NCT ID NCT02840994
Title A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bavarian Nordic, Inc.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

CV301 + Nivolumab

Nivolumab

Age Groups: adult senior

No variant requirements are available.